Delivery Order SPE2DB22D1200-SPE2DB25FN0FV

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,601.97 firm-fixed-price contract is for the delivery of UBRELVY 100 MG TABLET UD 16S, a pharmaceutical product. The contract has an ultimate completion date of November 21, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The order has a ceiling value of $8,337.85 and a completion date of July 30, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,385.19, is for the delivery of UBRELVY 100 MG TABLET UD 10S, a specialty medication. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,729.98 contract is for the supply of UBRELVY 100 MG TABLET UD 10S, a medical product, with a period of performance through January 13, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,436.97 order is for UBRELVY 100 MG TABLET UD 16S and has a completion date of March 7, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation noted. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,514.14, is for the delivery of UBRELVY 50 MG TABLET UD 10S, a medical supply item. The contract has a firm fixed price pricing type and a period of performance through January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,319.61, is for the delivery of UBRELVY 50 MG TABLET UD 10S. It is a firm fixed-price contract, with a period of performance through January 29, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the supply of UBRELVY 100 MG TABLET UD 16S, a specialty pharmaceutical product. The total ceiling value of the order is $7,359.94, with an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., doing business as Amerisourcebergen. This delivery order is part...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,146.60, is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. This is a firm fixed-price contract with a performance period through January 6, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,374.60 firm-fixed-price contract is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2023 and was awarded on December 15, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB25FN0FV
    Delivery Order

This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of UBRELVY 100 MG TABLET UD 10S medication. The contract has a ceiling value of $7,548.63 and is a firm-fixed-price delivery order with a completion date of February 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated as a set-aside contract.

Generated 5/7/25, 10:00 AM